Ronnie C. Mease

Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

Zsolt Szabó, Esther Mena, Steven P. Rowe et al. · Molecular Imaging and Biology · 2015 · 441 citations · Full text

Positron Emission Tomography, Engineering, Oncologic Imaging +11

2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

Ying Chen, Mrudula Pullambhatla, Catherine A. Foss et al. · Clinical Cancer Research · 2011 · 389 citations · Full text

Biodistribution, Tumor Detection, and Radiation Dosimetry of ¹⁸F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

Steve Y. Cho, Kenneth L. Gage, Ronnie C. Mease et al. · Journal of Nuclear Medicine · 2012 · 277 citations · Full text

Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen:<i>In vivo</i>Imaging in Experimental Models of Prostate Cancer

Catherine A. Foss, Ronnie C. Mease, Hong Fan et al. · Clinical Cancer Research · 2005 · 260 citations · Full text

PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

Steven P. Rowe, Katarzyna J. Macura, Esther Mena et al. · Molecular Imaging and Biology · 2016 · 253 citations · Full text

Positron Emission Tomography, Metastatic Prostate Cancer, Urology +13